Abstract
An inhibition enzyme immunoassay (IEIA), using a human monoclonal antibody (K14) reactive with gp41 of HIV-1, was evaluated for its applicability to the serology of HIV-1 infections. Using panels of serum samples from seronegative and confirmed HIV-1-seropositive individuals, it was shown that all the HIV-1-positive samples in a panel from The Netherlands and 97% of the HIV-1-positive samples from Tanzania were identified by this IEIA. Six per cent of the IEIA-positive samples from Tanzania could not be confirmed in other assays. Testing of serial dilutions of serum samples from African individuals with confirmed HIV-1, HIV-2 or HIV ANT70 infections in the K14 IEIA, indicated that a HIV-1-specific assay based on this principle may be developed.
| Original language | English |
|---|---|
| Journal | AIDS |
| Volume | 5 |
| Issue number | 7 |
| Pages (from-to) | 893-896 |
| ISSN | 0269-9370 |
| DOIs | |
| Publication status | Published - 1991 |
Keywords
- B780-tropical-medicine
- Virology
- HIV-1
- Serology
- Immunoenzyme techniques
- Inhibition enzyme immunoassay
- Monoclonal antibodies
- Laboratory techniques and procedures
Fingerprint
Dive into the research topics of 'An inhibition enzyme immunoassay using a human monoclonal antibody (K14) reactive with gp41 of HIV-1 for the serology of HIV-1 infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver